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Previous studies from our laboratory indicated that a 28-amino-acid carboxyl-terminal truncation of gB caused extensive
virus-induced cell fusion (Baghian et al., 1993, J Virol 67, 2396–2401). We tested the ability of additional truncations and
mutations within gB to cause cell fusion in the recently established virus-free cell fusion assay (Turner et al., 1998, J. Virol.
72, 873–875). Deletion of the carboxyl-terminal 28 amino acids of gB (gBD28), which removed part of the predicted a-helical
structure H17b, caused extensive cell fusion. A gB truncation specified by gBD36, which removed the entire H17b domain,
caused as much cell fusion as the gBD28 truncation. Similarly, gB(A874P) containing a substitution of an Ala with Pro within
H17b caused cell fusion. Heparin, a gB-specific inhibitor of virus-induced cell fusion, inhibited both wild-type gB and
gB(syn3)-mediated cell fusion. In contrast, fusion of cells transfected with gB(D28), gB(D36), or gB(A874P) was resistant to
heparin inhibition of cell fusion. We concluded the following: (1) The predicted a-helical structure of H17b within the carboxyl
terminus of gB is involved in both virus-induced and virus-free cell fusion. (2) Heparin is a specific inhibitor of gB-mediated
fusion in both systems. (3) Resistance to heparin inhibition of gB-mediated cell fusion is associated with the predicted
a-helical structure H17b within the carboxyl terminus of gB. © 2001 Academic PressINTRODUCTION
Viral glycoproteins are key determinants in membrane
fusion events throughout the virus life cycle. Herpes
simplex viruses specify at least twelve glycoproteins: gB,
gC, gD, gE, gG, gH, gI, gJ, gK, gL gM, and gN, which are
expressed in infected cells. These glycoproteins function
in several important roles, including pH-independent vi-
rus entry via fusion of the viral envelope with cellular
membranes, cell-to-cell spread, virus-induced cell fu-
sion, and egress of infectious virion particles (reviewed
in Mettenleiter, 2000; Spear, 1993). Recombinant mutant
viruses that lack gB (UL27), gD (US6), gH (UL22), or gL
(UL1) attach to cell surfaces through cell-surface glycos-
aminoglycans, but fail to penetrate, indicating these gly-
coproteins are required at least in part for virus-to-cell
fusion (Cai et al., 1988; Forrester et al., 1992; Ligas and
Johnson, 1988; Roop et al., 1993). Either of two HSV-1
glycoproteins, gC (UL44) or gB, can mediate binding of
virus to heparan sulfate proteoglycans on cellular sur-
faces. Accordingly, attachment is inhibited by soluble
heparin, a glycosaminoglycan closely related to heparan
sulfate (Gruenheid et al., 1993; Herold et al., 1991, 1994;
Shieh et al., 1992; WuDunn and Spear, 1989). Fusion
between the viral envelope and cell membrane requires
gB, gD, and gH/gL, and possibly the tegument protein
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18UL25 (Addison et al., 1984; Cai et al., 1988; Forrester et
al., 1992; Ligas and Johnson, 1988; Roop et al., 1993).
Penetration of virus requires the interaction of gD with
specific cell surface receptors (Cocchi et al., 1998; Ger-
aghty et al., 1998; Montgomery et al., 1996; Warner et al.,
1998).
Spread of infectious virus occurs either by release of
virions to extracellular spaces or through virus-induced
cell-to-cell fusion. Mutations, which cause extensive vi-
rus induced cell-to-cell fusion, can arise in at least four
genes of the HSV genome: the UL53-gK gene, the gB
gene, the UL20 gene, and the UL24 gene (Baines et al.,
1991; Bond and Person, 1984; Bzik et al., 1984b; Cai et al.,
1988; Debroy et al., 1985; DeLuca et al., 1982; Dolter et
al., 1994; Engel et al., 1993; Gage et al., 1993; Hutchinson
et al., 1992; Jacobson et al., 1989; Pogue-Geile and Spear,
1987; Ruyechan et al., 1979; Sanders et al., 1982; Weise et
al., 1987). However, like virus-to-cell fusion, gB, gD, gH,
and gL have been shown to be necessary and sufficient
to cause virus-induced cell fusion. The evidence is two-
fold. First, mutant viruses that do not express any one of
these four glycoproteins fail to produce syncytia (Cai et
al., 1988; Davis-Poynter et al., 1994; Ligas and Johnson,
1988; Roop et al., 1993). Similarly, transient expression of
HSV-1 or HSV-2 gB, gD, gH, and gL causes polykaryocyte
formation in transfected Cos cells (Muggeridge, 2000;
Turner et al., 1998). Glycoproteins gE (US8), gI (US7), and
gM (UL10), as well as the UL45 protein, may be able to
enhance virus-induced cell fusion, since deletions of
these genes cause inhibition of cell fusion (Davis-Poyn-
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19gB AND HEPARIN INHIBITION OF CELL FUSIONter et al., 1994; Haanes et al., 1994; Visalli and Brandt,
1991). Similarly, gC may be able to inhibit virus-induced
cell fusion of at least some cell types, which may explain
the lack of gC expression in many syncytial mutants
(Manservigi et al., 1977; Novotny et al., 1996; Pertel and
Spear, 1996). It is apparent there are similarities as well
as significant differences between the virus-induced cell
fusion and fusion of cells by transient co-expression of
gB, gD, and gH/gL. Both systems require the expression
of gD receptors for fusion to occur (Pertel et al., 2001;
erry-Allison et al., 1998); however, the transient expres-
ion system, in contrast to the virus-induced cell fusion,
oes not require the presence of heparan sulfate (Pertel
t al., 2001; Shieh and Spear, 1994). Additionally, viral
roteins that exhibit the ability to influence virus-induced
ell fusion do not produce similar effects in the transient
usion assay system (Klupp et al., 2000; Turner et al.,
998).
Glycoprotein B is highly conserved across all subfam-
lies of herpesviruses. It exists within cells as a ho-
odimeric type I integral membrane protein that is N-
lycosylated at multiple sites within the polypeptide.
ach 904-amino-acid (aa) monomer includes a cleavable
ignal sequence, an extracellular domain of 696 aa, a
9-aa triple-pass transmembrane region, and a 109-aa
arboxyl-terminal domain. Single amino acid substitu-
ions within two regions of the intracellular cytoplasmic
omain of gB were shown to cause syncytium formation
nd were designated Region I (aa positions 816 and 817)
nd Region II (aa positions 853, 854, and 857) (Bzik et al.,
984a; Cai et al., 1988; Gage et al., 1993; Walev et al.,
994). Deletion of the carboxyl-terminal 41 amino acids of
B did not adversely affect viral infectivity and replica-
ion; whereas, deletion of 28 amino acids caused exten-
ive virus-induced cell fusion (Baghian et al., 1993; Huff
et al., 1988).
We extended our previous findings by examining the
role of specific carboxyl-terminal domains of gB in cell
fusion in the context of viral infection as well as in a
transfection-fusion system. We show that an a-helical
domain within the gB carboxyl terminus appears to reg-
ulate cell fusion. Moreover, we provide evidence that
heparin inhibition of gB-mediated cell fusion is also reg-
ulated by the carboxyl terminus of gB for both virus-
induced cell fusion as well as fusion by co-expression of
gB, gD, and gH/gL. In this regard, gB-mediated fusion
functions similarly for both fusion systems.
RESULTS
The effect of gB truncations on virus-independent cell
fusion
Previously, we investigated the effect of several gB
truncations on virus-induced cell fusion. We found that a
recombinant virus expressing a 28-amino-acid truncated
gB resulted in extensive virus-induced cell fusion
(Baghian et al., 1993). A schematic of the predicted struc-ture of the carboxyl terminus of gB showing the location
of relevant truncations and mutations is shown in Fig. 1.
The 28-amino-acid deletion of gB disrupts the predicted
a-helical structure H17b composed of 16 amino acids. To
assess whether these gB truncations caused similar
effects in a virus-independent cell fusion assay, we
transfected COS7 cells with plasmids constitutively ex-
pressing glycoproteins gD, gH, and gL in the presence of
different mutated gB (Fig. 2). The extent of cell fusion was
quantified by counting nuclei in 100 polykaryocytes per
assay by two independent observers (Fig. 3, Table 1). As
shown previously, transient expression of full-length,
wild-type gB, gD, gH, and gL genes under the human
cytomegalovirus immediate early promoter (CMV-IE)
caused limited polykaryocyte formation (Turner et al.,
1998) (Fig. 2A). Similar numbers of polykaryocytes were
formed when the CMV-IE driven gB gene was substituted
with plasmid p9–2080 expressing gB under the adeno-
virus major late promoter (Ad-MLP). (Fig. 2B). Transfec-
tion controls that did not include gB failed to cause any
cell fusion (data not shown). Similarly, inclusion of p9–
1537 in the transfection fusion assay failed to cause any
cell fusion (Fig. 2C). Plasmid p9–1537 specifies gB con-
taining an internal, in-frame truncation spanning amino
acids 130–697. This deletion causes rapid degradation of
the gB product (Baghian et al., 1993).
All gB mutants, which modified H17b, used in these
experiments expressed high levels of gB and similar
amounts of gB were detected on cell surfaces by immu-
nofluorescence against paraformaldehyde-fixed trans-
fected cells (Baghian et al., 1993; data not shown). Trans-
fection with p9–1511 caused more than twofold increase
in cell fusion in comparison to wild-type gB (Fig. 2F, Table
1). An identical truncation of 28 amino acids in gB spec-
ified by mutant virus amb1511 caused extensive cell
fusion (Baghian et al., 1993). Interestingly, transfection of
the 1511(gBD28) plasmid mixture resulted in fusion of the
entire cell monolayer (8 3 106 cells) within 48–72 h after
transfection (data not shown).
Transfections with p9–1513 or p9–1528 specifying gB
truncations of 64 and 49 amino acids, respectively, both
of which disrupt the predicted a-helical region H17a,
aused substantially less cell fusion (approximately 50%
eduction) than that of the wild-type gB gene (Figs. 2D
nd 2E; Table 1). Previously, we showed that gB specified
y p9–1513 and p9–1528 was not as efficiently processed
hrough the Golgi as the gB specified by p9–2080 (wild-
ype) or p9–1511 (Baghian et al., 1993). Therefore, the
nability of these two mutant forms of gB to cause cell
usion may be due to their altered processing and trans-
ort to cell surfaces.
he role of a-helical domain H17b in cell fusion
The 1511 gB truncation interrupted the predicted a-he-
lical domain H17b, allowing only the first half of this
domain to be expressed (Fig. 1) (Baghian et al., 1993;
Pellett et al., 1985). To further assess the role of this
pw
20 FOSTER, MELANCON, AND KOUSOULASdomain in the transient fusion assay, additional mutated
gB genes were constructed and tested for their ability to
cause cell fusion. Plasmid pCMV-gB(D36) specifies a gB
truncated immediately before the H17b domain, while
plasmid pCMV-gB(D16) specifies gB truncated after the
FIG. 1. Schematic diagram of the carboxyl terminus of HSV-1 gB. Th
is shown as described previously (Baghian et al., 1993; Pellett et al., 19
9–1513, p9–1528, p9–1511, pCMV-gB(D28), pCMV-gB(D36), pCMV-gB(A
number indicates the number of amino acids deleted from the carboxy
are shown and marked by dashed lines.H17b domain (Fig. 1). The gB(D16) truncation produced
ere visualized by IFA at 36 h after transfection (653 magnification).fusion similar to wild-type gB (Figs. 4A and 4C). In con-
trast, gB(D36) caused similar levels of cell fusion to
gB(D28) (Figs. 4D and 4E). To evaluate the role of the
predicted a-helical structure of the H17b domain in cell
fusion, a single amino replacement was engineered into
cted secondary structure of the gB carboxyl-terminal 109 amino acids
e location of the gB truncations and mutations specified by plasmids
pCMV-gB(D16), and pCMV-gB(syn3) are shown. The D followed by a
us of gB. The location of the two predicted a-helices, H17a and H17b,e predi
85). Th
874P),
l terminthe H17b domain by replacing alanine 874 with proline,FIG. 2. Truncation of the carboxyl-terminal 28 amino acid of gB causes extensive fusion of transfected Cos cells. Cells were transfected with
plasmids expressing gD, gH/gL, and plasmids pCMV-gB (A), p9–2080 (B), p9–1537 (C), p9–1513 (D), p9–1528 (E), and p9–1511 (F). Transfected cells
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21gB AND HEPARIN INHIBITION OF CELL FUSIONcausing disruption of the predicted a-helical structure
Fig. 1). Expression of gB(A874P) produced cell fusion
imilar to gB(D28) and gB(D36) (Figs. 4D–4F). For com-
arative purposes, we tested the ability of gB specified
y syncytial mutant HFEM(tsB5), which contains a mis-
sense syncytial mutation within the H17a a-helix, to
ause cell fusion. Transient expression of the gB(syn3)
ene did not increase cell fusion relative to the wild-type
B, in agreement with results obtained with other HSV-1
B syncytial mutations (Turner et al., 1998) (Figs. 4A and
B). Polykaryocyte formation was quantified by counting
ropidium iodide stained nuclei as explained earlier.
esults are summarized in Table 2.
he effect of heparin on gB-mediated cell fusion
Heparin is a potent inhibitor of virus penetration as
FIG. 3. Quantitation of the effect of gB truncation on fusion of transfec
observers and the average values and standard deviation were calculell as gB-mediated (syn3) virus-induced cell fusionGruenheid et al., 1993; Herold et al., 1991, 1994; Shieh
et al., 1992; WuDunn and Spear, 1989). Transfected cell
monolayers were incubated either in the presence or
absence of heparin (10 mg/ml). Cell fusion was visu-
alized through fluorescence microscopy and the levels
of observed cell fusion were quantified (Figs. 5 and 6).
Incubation of transfected cell monolayers with heparin
inhibited both wild-type gB and gB(syn3)-mediated cell
fusion (;85% inhibition) (Figs. 4, 5A, and 5B; Table 3)
as previously reported for tsB5 virus-induced cell fu-
sion (Seck et al., 1994). In contrast, fusion of cells
expressing gB(D28) or gB(D36) was largely resistant to
heparin inhibition (Figs. 4, 5D, and 5E). Cell fusion
caused by gB(A874P) was inhibited by approximately
40% in heparin treated vs. untreated controls (Figs. 4
and 5F; Table 3). Heparin inhibited fusion caused by
gB(D16) by approximately 58% (Figs. 4 and 5C; Ta-
s cells. Nuclei in 100 IFA-positive cells per assay were counted by twoble 3).TABLE 1
Truncation of the Carboxyl Terminal 28 Amino Acid of gB Causes Extensive Fusion of Transfected Cos Cells
Plasmids transfected
(all include gD, gHgL) gB 2080 1537 1528 1513 1511
Total nuclei counted 1838 1561 444 888 762 4460
Average nuclei 9.19 7.81 2.22 4.44 3.81 22.30
Standard deviation 6.98 6.58 1.92 4.32 2.58 20.21
Standard error 0.49 0.47 0.14 0.31 0.18 1.43
Median 8 6 2 3 3 16
Smallest no. of nuclei 1 1 1 1 1 1
Largest no. of nuclei 51 52 17 34 15 129
% change from gB — 215.1% 275.8% 251.7% 258.5% 142.7%ted Co
ated.
22 FOSTER, MELANCON, AND KOUSOULASThe effect of heparin on virus-induced cell fusion
Heparin was unable to fully inhibit cell fusion mediated
by truncated or mutated gB in the transient fusion assay.
Therefore, we assayed the effect of heparin on virus-
T
gB-H17b-Targeted Mutations Enh
Plasmids transfected
(all include gD, gHgL) gB
gB
(syn3)
Total nuclei counted 2035 2340
Average nuclei 10.18 11.7
Standard deviation 6.93 8.61
Standard error 0.49 0.61
Median 9 11
Smallest no. of nuclei 1 1
Largest no. of nuclei 41 44
% Increase over wt gB — 14.9%
FIG. 4. gB-H17b-targeted mutations enhance fusion of transfected C
gB(syn3) (B), gB(D16) (C), gB(D28) (D), gB (D36) (E), and gB (A874P) (F
magnification.induced cell fusion caused by syncytial mutant viruses.
Syncytial viruses mp(MP), HFEM(tsB5), and amb1511
were engineered to constitutively express EGFP as de-
scribed previously for the construction of the KOS/EGFP
usion of Transfected Cos Cells
gB
(D16)
gB
(D28)
gB
(D36)
gB
(A874P)
2 4146 4332 4000
1.16 20.73 21.66 20
7.81 15.62 17.36 14.33
0.55 1.1 1.23 1.01
0 17 18 18
1 1 1 1
7 92 99 80
9.6% 103.6% 112.8% 96.5%
ls. Cells transfected with plasmids expressing gD, gH/gL, and gB (A),
sfected cells were visualized by IFA at 36 h after transfection at 653ABLE 2
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23gB AND HEPARIN INHIBITION OF CELL FUSIONvirus (Foster et al., 1999). Expression of EGFP from this
locus results in distinct nuclear and diffuse cytoplasmic
fluorescence, facilitating visualization of polykaryocytes
(Fig. 7). As previously reported (Seck et al., 1994), tsB5-
T
gB-H17b-Targeted Mutations Confer Re
Plasmids transfected
(all include gD, gHgL) gB
gB
(syn3)
otal nuclei counted 471 486
verage nuclei 2.36 2.43
tandard deviation 1.93 2.14
tandard error 0.13 0.15
edian 2 2
mallest no. of nuclei 1 1
argest no. of nuclei 10 14
Inhibition by heparin 85.2% 86.6%
FIG. 5. gB-H17b-targeted mutations confer resistance to heparin inhib
B (A), gB(syn3) (B), gB(D16) (C), gB(D28) (D), gB (D36) (E), and gB (A874
isualized by IFA at 36 h after transfection at 653 magnification.induced cell fusion was inhibited by heparin (Figs. 7C
and 7D). In contrast, fusion caused by mp(MP), which
contains the syn1 mutation in glycoprotein K (gK), was
not inhibited by heparin (Figs. 7G and 7H). Similar to the
ce to Heparin Inhibition of Cell Fusion
gB
(D16)
gB
(D28)
gB
(D36)
gB
(A874P)
59 3414 3397 2543
5.3 17.07 16.99 12.72
5.07 10.95 14.04 9.31
1.1 0.77 0.99 0.66
3 16 13 11
1 1 1 1
26 55 91 50
57.7% 18.6% 22.6% 38.3%
cell fusion. Cells transfected with plasmids expressing gD, gH/gL, and
ells were incubated in the presence of heparin. Transfected cells wereABLE 3
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24 FOSTER, MELANCON, AND KOUSOULASresults obtained in the transient fusion assay, cell fusion
caused by mutant virus-amb1511/EGFP was resistant to
eparin inhibition (Figs. 7E and 7F).
DISCUSSION
Studies on the role of individual viral glycoproteins in
irus entry as well as virus-induced cell fusion are ham-
ered by the fact that multiple glycoproteins and proteins
re involved in both processes. In this regard, the estab-
ished model system for virus-associated membrane fu-
ion phenomena via transient co-expression of gB, gD,
nd gH/gL represents a reasonable model system to
nvestigate individual glycoprotein functions. However, it
s important to compare virus-induced cell fusion and
irus-free fusion systems to ensure that functional as-
ects of glycoproteins expressed in the transfection fu-
ion system represent glycoprotein functions manifested
n the context of the viral genome. Our investigations
roduced the following conclusions. First, we show that
he predicted a-helical domain H17b within the carboxyl
terminus of gB is involved in both virus-induced and
virus-free fusion systems. Second, heparin is a specific
inhibitor of gB-mediated fusion in both systems. Third,
resistance to heparin inhibition of gB-mediated cell fu-
sion is associated with the predicted a-helical structure
H17b. Thus, gB-mediated fusion is functionally similar for
both fusion assays.
Previously, we showed that truncating gB by 28 amino
acids produced wild-type levels of mature gB and
caused extensive virus-induced cell fusion (Baghian et
al., 1993), while a truncation of 41 amino acids did not
affect virus replication and failed to cause cell fusion
FIG. 6. Quantitative comparison of fusion of transfected cells in the
heparin) and Fig. 5 (with heparin) was quantitated as described in the(Huff et al., 1988). We proposed that the a-helical domain17b, which was interrupted by the 28-amino-acid trun-
ation, must be involved in virus-induced cell fusion
Baghian et al., 1993). Co-expression of the 28-amino-
cid truncated gB specified by plasmid p9–1511 with gD,
and gH/gL caused extensive cell fusion as evidenced by
the formation of large-size polykaryocytes. The extent of
the fusion occurring after cotransfection of glycoprotein
genes containing the truncated gB was similar to virus-
induced cell fusion caused by mutant viruses expressing
the gB (syn3) or gB(D28). Ultimately, transfection of Cos
cells led to fusion of the entire cell monolayer of up to
5 3 106 cells into a single syncytium within 48–72 h.
Clearly, the 28-amino-acid gB deletion functioned simi-
larly in both the virus-induced cell fusion and virus-free
transfection fusion assay. Three conclusions can be
made based on these results. First, the ability of trun-
cated gB to cause extensive cell fusion in the transfec-
tion fusion assay provides further evidence that certain
gB functions can be manifested in the absence of pro-
ductive viral replication. Second, the truncated gB’s abil-
ity to extensively fuse membranes requires only the pres-
ence of co-expressed gD and gH/gL glycoproteins. Third,
the domains of gB that are responsible for this extensive
cell fusion phenotype, in both virus-induced and virus-
free transfection systems, are located in the carboxyl
terminus of gB.
In agreement with our previous results, which impli-
cated the H17b a-helical domain in virus-induced cell
fusion, we found that deletion of the entire H17b domain
or substitution of a single proline within the H17b helical
domain caused extensive cell fusion as evidenced by the
formation of large-size polykaryocytes. The ability of the
ce and absence of heparin. Cell fusion represented in Fig. 4 (without
of Fig. 3.presentwo gB truncations and the single proline residue sub-
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25gB AND HEPARIN INHIBITION OF CELL FUSIONstitution to cause extensive cell fusion indicates that the
predicted a-helical structure of H17b serves as a major
determinant for membrane fusion. All gB mutants, which
disrupted the predicted a-helical domain H17b either by
runcation or the proline substitution did not affect gB
ynthesis or transport to cell surfaces as evidenced by
mmunofluorescence against transfected cells fixed with
% paraformaldehyde (not shown). Therefore, the ability
f these mutant gB forms to cause cell fusion is largely
ue to their specific gB mutations. H17b is located im-
ediately adjacent to the predicted 31-amino-acid-long
a-helix, H17a, within which multiple syncytial mutations
FIG. 7. Cell fusion caused by viruses specifying H17b-mutated gB is
KOS/EGFP (A, B), tsb5/EGFP (C, D), amb1511/EGFP (E, F), and MP/EGFP
cells were visualized by fluorescence microscopy (653 magnification)have been mapped (Bzik et al., 1984a; Gage et al., 1993).However, syncytial mutations within H17a and H17b can
be functionally differentiated with respect to their ability
to cause membrane fusion in the transfection fusion
system. The syn3 mutation within H17a failed to enhance
fusion in the transfection fusion assay. In contrast, both
the 36- and 28-amino-acid truncations as well as the
proline substitution affecting H17b readily caused exten-
sive cell fusion. The most plausible explanation for these
results is that H17b functions as an independent fusion
domain regulator. Partial or full inactivation of this do-
main confers the ability on gB to cause extensive cell
fusion. Furthermore, fusion associated with this domain
nt to heparin inhibition. Vero cells were infected at an m.o.i. of 0.1 with
in the presence (B, D, F, H) or absence (A, C, E, G) of heparin. Infectedresista
(G, H)requires the presence of only gD and gH/gL. In contrast,
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26 FOSTER, MELANCON, AND KOUSOULASthe H17a domain must require additional viral proteins
expressed during viral infection. Truncations and muta-
tions in the gH carboxyl terminus have been shown to
inhibit cell fusion implying that the carboxyl terminus of
gH is also involved in membrane fusion (Browne et al.,
1996; Wilson et al., 1994). An alternative explanation of
the role of the H17b domain in cell fusion is that the
carboxyl termini of gB and gH functionally interact and
this interaction affects the fusogenic abilities of both gB
and gH. It is worth noting that there is a discrepancy
between trasfection fusion results obtained with HSV-1
and HSV-2 glycoproteins, inasmuch as a syn mutation
within HSV-2 gB was reported to enhance fusion in the
transfection fusion system (Muggeridge, 2000). HSV-2
enters faster into cells than HSV-1 implying the presence
of an enhanced mechanism for virus-to-cell fusion (De-
Luca, 1981, Kousoulas, unpublished observations).
Therefore, the different dynamics of HSV-1 and HSV-2
glycoprotein-mediated membrane fusion phenomena
may account for the observed differences in fusion
caused by syncytial mutations within HSV-1 and HSV-2
gB.
Heparin is a specific inhibitor of gB-mediated virus-
induced cell fusion (Seck et al., 1994). In agreement with
previous reports, we confirmed that heparin specifically
inhibited fusion caused by syncytial mutant HFEM (tsB5),
while it did not inhibit fusion caused by mutants with
syncytial mutations in gK. Heparin is known to predom-
inantly bind to gC and secondarily to gB (Herold et al.,
1991, 1994; Laquerre et al., 1998; Spear et al., 1992). The
binding sites of other proteins exhibiting heparin-binding
activity have been mapped to dense regions of positively
charged residues containing variable lengths of argi-
nine-rich and/or lysine-rich regions (Cardin et al., 1991;
arino et al., 1999; Sendak and Bensadoun, 1998;
endak et al., 2000; Wong et al., 1995). The primary
equence of gB contains a heparin binding site at amino
cids 68–76 (KPKKNKKPK) in the amino terminus of gB.
eletion of this amino acid domain results in substantial
eduction in heparin binding of gB (Laquerre et al., 1998).
here are additional potential heparin binding sites
ithin gB at amino acid locations 158, 318, 494, 862, and
82 containing the consensus binding motif R/K-X-R/K.
he simplest explanation for the inhibitory effect of hep-
rin on gB-mediated cell fusion is that heparin physically
locks cell fusion. Heparin inhibited fusion in the trans-
ection fusion system when full-copy gB, gD, and gH/gL
ere co-expressed or when transfections contained the
B(syn3)gene. However, heparin was unable to substan-
ially inhibit fusion caused by truncations of gB that
elete all or part of the H17b a-helix. Heparin did partially
inhibit fusion caused by the single Ala to Pro substitution,
which inactivates the predicted a-helical structure of the
H17b domain. These differences between the truncated
gB and the proline substituted gB could be due to the
more severe nature of the truncations vs. the single
amino acid replacement in that certain amino acids up- cstream or downstream of the proline substitution may
confer partial susceptibility to heparin inhibition of mem-
brane fusion. We offer the following hypotheses to ex-
plain the effect of heparin on gB-mediated cell fusion.
First, truncation of gB may affect the conformation of the
gB amino terminus resulting in the partial loss of heparin
binding. Second, gB truncations may cause changes in
the interaction of gB with cellular receptors, which ren-
der gB-mediated fusion resistant to heparin. In support of
the latter hypothesis, it was shown that bovine herpes-
virus gB interacted with two types of receptors on Madin
Darby bovine kidney cells (MDBK), a heparan sulfate
proteoglycan, and an unknown high-affinity receptor, re-
spectively. Truncated gB retained the ability to bind hep-
arin, but not the ability to block the interaction of gB with
a high-affinity binding receptor on MDBK cells (Li et al.,
1996). Furthermore, deletion of the carboxyl terminus of
gB resulted in the loss of one monoclonal antibody
epitope located in the amino-terminal of gB, implying that
the truncated gB had assumed an altered conformation,
which was responsible for the loss of the binding to the
high-affinity receptor (Li et al., 1996). Additional evidence
hat perturbations of the carboxyl terminus of gB may
ffect the conformation of the gB extracellular portion
as provided by an Ala to Val change at position 851
ithin the syncytial region II of HSV-1 gB, which caused
elayed viral entry kinetics (Gage et al., 1993).
Substantial differences between the virus-induced and
ransfection-induced fusion systems exist with respect to
he role of heparan sulfate moieties on cell surfaces.
eparan sulfate enhanced virus-induced cell fusion, in-
smuch as viruses with syncytial mutations failed to
eadily fuse heparan sulfate-deficient cells. In contrast,
usion caused by transient transfection of viral glycopro-
eins did not require the presence of heparan sulfate,
lthough it did require the presence of cell surface entry
eceptors specific for gD (Pertel et al., 2001; Shieh and
pear, 1994). Therefore, the ability of heparin to inhibit
oth virus-induced cell fusion and virus-free fusion in the
ransfection fusion assay must reflect direct inhibition of
B-associated functions and not heparin-competitive in-
ibition of gB binding to heparan sulfate proteoglycans
n apposed cell surfaces. Such interactions, presumably,
ould strengthen interactions between plasma mem-
ranes and facilitate membrane fusion.
Heparin is known to bind to a variety of important
roteins on cell surfaces and modulate the functions of
hese proteins predominantly through signal transduc-
ion effects to intracellular targets. However, heparin can
lso internalize into cells via specific or nonspecific re-
eptors (Barzu et al., 1996; Heinzelmann et al., 1999;
etourneur et al., 1995a,b; Watanabe et al., 1995). There-
ore, it is possible that endocytosed heparin may directly
ind to the carboxyl terminus of gB at the predicted sites
ocated at amino acids 862 and 882. In this scenario,
esistance to heparin inhibition of cell fusion by trun-
ated gB may be due to the lack of heparin binding sites,
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27gB AND HEPARIN INHIBITION OF CELL FUSIONparticularly the site at amino acid 882, which is deleted
in both gB truncations. The reduced ability of heparin to
inhibit cell fusion caused by gB(A874P) and gB(D16) may
be the result of local conformational changes, which
prevent binding of heparin to upstream binding sites.
Additional experiments are needed to ascertain whether
heparin readily enters into gB-transfected cells and
whether the carboxyl terminus of gB is able to bind
heparin.
A carboxyl-terminal truncation of the PRV gB enhanced
both virus-induced and virus-free cell fusion (Klupp et al.,
000; Nixdorf et al., 2000). However, in the virus-free
ransfection assay, cell fusion can occur in the absence
f gD. Furthermore, a hybrid gD/gH protein composed of
he extracellular portion of gD fused in-frame to a portion
f gH, which contains the carboxyl terminus of gH in-
luding its membrane spanning region, functionally sub-
tituted the gH/gL heterodimer (Klupp and Mettenleiter,
999; Klupp et al., 2000). We constructed and tested a
imilar HSV-1 gD/gH fusion protein and found that it
ailed to substitute for the presence of gD or gH/gL in the
irus-free fusion system (not shown). Thus, it is clear that
here are similarities between PRV and HSV-1 with re-
pect to the role of the gB carboxyl terminus in cell
usion, but also substantial differences with respect to
he functions of gD and gH/gL. In this regard, the appar-
nt disparity between the two fusion systems may reflect
undamental differences in the functions of these pro-
eins as well as differences in their interactions with
ellular receptors (Nixdorf et al., 1999).
MATERIALS AND METHODS
ells and viruses
Vero and COS7 cells were obtained from ATCC (Rock-
ille, MD) and grown in Dulbecco’s modified Eagle’s
edium (DMEM) supplemented with 10% fetal calf se-
um (FCS). KOS/EGFP specifies the enhanced green flu-
rescence protein (EGFP) from a CMV-EGFP gene cas-
ette inserted within the intergenic region between the
L53 and UL54 open reading frames (ORFs) (Foster et
l., 1999). To facilitate visualization of syncytia formation,
ecombinant viruses amb1511/EGFP, MP/EGFP, and
sB5/EGFP were constructed by insertion of a CMV-
GFP gene cassette as described in detail previously for
he KOS/EGFP virus (Foster et al., 1999). All viruses were
ropagated on Vero cells.
onstruction of expression plasmids
Plasmid p9–2080 specifies a wild-type (wt) copy of gB;
hereas, plasmids p9–1511, p9–1513, p9–1528, and p9–
537 specify carboxyl-terminally truncated gB driven by
he Adenovirus Major Late Promoter (Ad MLP) and were
s described previously (Baghian et al., 1993). The entire
open reading frames (ORFs) for gB and gD were ampli-
fied by PCR with specific primers that removed the 39 nstop codon such that the genes were inserted in frame
with a V5 epitope tag when ligated to pcDNA3.1 TA TOPO
to generate plasmids pCMV-gB and pCMV-gD. Trunca-
tions in gB were generated by PCR. Plasmids gB(D36),
gB(D28), and gB(D16) express C-terminally truncated de-
rivates of gB of 36, 28, and 16 amino acids (aa), respec-
tively. A gB gene specifying a single codon change from
alanine to proline at amino acid 874 was produced by
splice-overlap extension (SOE) PCR utilizing synthetic
oligonucleotides containing the point mutation. The PCR-
derived gB(A874P) was ligated into pcDNA3.1 TA TOPO to
generate plasmid pCMV-gB(A874P). All plasmid inserts
were sequenced by Sanger dideoxy-chain termination
methodology using an automated DNA sequencer (PE
Biosystems, 377 Sequencer). Plasmid pcDNA3 gHgL
was kindly provided by A. Minson.
Cell fusion assay
In vitro cell fusion assays were performed essentially
as described previously (Klupp et al., 2000; Muggeridge,
2000; Turner et al., 1998). Briefly, the day prior to trans-
fection, 35-mm 6-well plates were seeded with 8 3 104
COS7 cells. A total of 6 mg of plasmid DNA encoding the
indicated glycoproteins was transfected with Superfect
(Qiagen, Valencia CA) according to the manufacturer’s
directions. Three hours post-transfection, media was as-
pirated and cells were overlaid with DMEM 5% FCS.
Where indicated, heparin (10 mg/ml) was included in the
overlay media. Twenty-four hours post-transfection, cells
were overlaid with 4 3 105 freshly trypsinized COS7 cells
er well with or without the inclusion of heparin. Cells
ere subsequently incubated at 37°C for an additional
2 h before levels of fusion were determined.
mmunofluorescence assay and quantitation of fusion
Cells were fixed with 100% methanol for 10 min,
ashed twice with TBS, and incubated at room temper-
ture for 1 h with the primary antibody anti-V5 (Invitrogen,
arlsbad, CA) diluted 1:200 in TBS-10% goat serum. Cells
ere then washed three times with TBS and incubated
or 1 h at room temperature with FITC-conjugated goat
nti-mouse IgG (Sigma, St. Louis, MO) diluted 1:100 in
BS-10% goat serum. After incubation, excess antibody
as removed by washing three times with TBS. Pro-
idium iodide nuclear counterstain (Molecular Probes,
ugene, OR) was applied to facilitate quantitation of
usion. Fusion was examined on a Nikon Diaphot in-
erted fluorescent microscope. The number of nuclei in
00 transfected cells or polykaryocytes per well was
etermined by two independent observers. Transfected
ells were defined as those cells that were IFA-positive.
verage values and standard deviations were then cal-
ulated from the combined data obtained by the two
bservers. Percent change in levels of fusion over wild-
ype (wt) gB was calculated by the formula [(average
uclei mutated gB) 2 (average nuclei wt gB)]/(average
GH
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28 FOSTER, MELANCON, AND KOUSOULASnuclei wt gB) 3 100%. Percent inhibition of fusion by
heparin was defined as {[(average nuclei of untreated
assay) 2 1] 2 [(average nuclei of heparin treated as-
say) 2 1]}/[(average nuclei of untreated assay) 2 1] 3
100%.
Heparin inhibition of viral polykaryocyte formation
Subconfluent Vero cells were infected at an m.o.i. of
0.1 for 1 h and subsequently overlaid with DMEM-2%
FCS, 1% methylcellulose either lacking or containing
heparin (10mg/ml). The amount of heparin used in the
virus-free fusion inhibition experiments was chosen on
the basis of being the amount required to inhibit virus-
induced cell fusion. Lower amounts of heparin (1 mg/ml
instead of 10 mg/ml), effectively inhibited virus-free fu-
sion caused by wild-type gB. Viral plaques were visual-
ized by phase-contrast and fluorescent microscopy at
24 h post-infection.
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